glp-1 diabetes news The popularity of drugs has exploded. Once a relatively obscure class of drugs prescribed for people with diabetes, GLP-1s have now shown an impressive ability to treat obesity, which affects Dr. Jandial breaks down microdosing
Description
Murthy, G
JoinFridays has an intake form where you fill out your health information
According to recent data, BED affects individuals worldwide, with a prevalence of approximately 1-3 percent globally
The goal is to activate GLP-1 in the body through both nutrition and supplements
Despite their rollout on the NHS, research in the British Medical Journal highlights how stopping weight-loss drugs can have regressive effects, with many patients rapidly regaining weight once treatment ends
